Predilytics has secured $10 million in additional funding in a Series C round led by Qualcomm Ventures. Existing investors Flybridge Capital Partners, Foundation Medical, and Highland Capital also participated in the round.

Predilytics is a healthcare IT company, the first to commercially employ in healthcare the analytic techniques and processes that have demonstrated long-term success in other sectors such as financial services and consumer products. The Burlington, MA-based company applies patented, machine-learning analytic tools to transform structured and unstructured client data, along with external data sources, into actionable insights.

“The healthcare industry is facing unprecedented challenges that require new powerful analytic approaches and advanced technology to enable health organizations to better engage consumers and providers,” said Chris Coloian, Predilytics’ President & CEO. “Healthcare must more effectively target resources to deliver better outcomes; this can only be accomplished by better understanding individual consumers and providers.”

“Predilytics’ approach of leveraging their consumer data set is unique in healthcare,” said Jack Young, Qualcomm Ventures’ senior director. “We are pleased to collaborate with the company as it continues to drive technology innovation in the rapidly changing healthcare space.”